olmesartan has been researched along with Ureteral Obstruction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, YY; Fujisawa, Y; Hase, N; Hitomi, H; Kiyomoto, H; Kobori, H; Kohno, M; Matsuura, J; Nakano, D; Nishiyama, A; Urata, H | 1 |
| Kato, M; Mizuno, M; Sada, T; Terashima, H; Tsuchida, H; Yasumo, H | 1 |
2 other study(ies) available for olmesartan and Ureteral Obstruction
| Article | Year |
|---|---|
Contribution of chymase-dependent angiotensin II formation to the progression of tubulointerstitial fibrosis in obstructed kidneys in hamsters.
Topics: Actins; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Blood Urea Nitrogen; Butyrates; Chymases; Collagen Type I; Cricetinae; Disease Progression; Imidazoles; Kidney; Male; Mesocricetus; Nephritis, Interstitial; Organ Size; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Tetrazoles; Thiophenes; Transforming Growth Factor beta; Ureteral Obstruction | 2009 |
A sensitive short-term evaluation of antifibrotic effects using newly established type I collagen reporter transgenic rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzamides; Collagen; Collagen Type I; Collagen Type I, alpha 1 Chain; Dioxoles; Disease Models, Animal; Fibrosis; Genes, Reporter; Hydroxyproline; Imidazoles; Kidney; Luciferases; Male; Protein Serine-Threonine Kinases; Rats; Rats, Transgenic; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; Sensitivity and Specificity; Tetrazoles; Ureteral Obstruction | 2010 |